8 Grants
2021
Adipose-derived stem cell-conditioned medium therapy in a mouse model of ALS
Walker, Chandler
National Institutes of Health (NIH), Veterans Affairs (VA) (ID: 5IK2RX002688-03), 2019-04-01 -- 2024-03-31
2020
Adipose-derived stem cell-conditioned medium therapy in a mouse model of ALS
Walker, Chandler
National Institutes of Health (NIH), Veterans Affairs (VA) (ID: 5IK2RX002688-02), 2019-04-01 -- 2024-03-31
2019
Adipose-derived stem cell-conditioned medium therapy in a mouse model of ALS
Walker, Chandler
National Institutes of Health (NIH), Veterans Affairs (VA) (ID: 1IK2RX002688-01A2), 04/01/2019 -- 03/31/2024
2016
Immediate-early intra-axonal signaling in neurodegeneration
Walker, Chandler A
National Institutes of Health (NIH), National Institute on Aging (NIA) (ID: 5R36AG050696-02), $69,402USD, 09/01/2015 -- 04/30/2017
2015
Immediate-early intra-axonal signaling in neurodegeneration
Walker, Chandler A
National Institutes of Health (NIH), National Institute on Aging (NIA) (ID: 1R36AG050696-01), $68,672USD, 09/01/2015 -- 04/30/2017
2013
Grafting genetically-modified Schwann cells into a clinically-relevant SCI model
Walker, Chandler
National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS) (ID: 5F31NS071863-03), $15,016USD, 02/04/2011 -- 07/31/2013
2012
Grafting genetically-modified Schwann cells into a clinically-relevant SCI model
Walker, Chandler
National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS) (ID: 5F31NS071863-02), $30,877USD, 02/04/2011 -- 02/03/2014
2011
Grafting genetically-modified Schwann cells into a clinically-relevant SCI model
Walker, Chandler
National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS) (ID: 1F31NS071863-01A1), $31,334USD, 02/04/2011 -- 02/03/2014